A Phase 2 Study of 99mTc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer

被引:0
|
作者
Stanley P. L. Leong
Julian Kim
Merrick Ross
Mark Faries
Charles R. Scoggins
Wendy L. Rich Metz
Frederick O. Cope
Richard C. Orahood
机构
[1] University of California,California Pacific Medical Center and Sutter Pacific Medical Foundation and Research Institute
[2] University Hospitals Case Medical Center,Department of Surgical Oncology
[3] M. D. Anderson Cancer Center,Department of Surgery
[4] John Wayne Cancer Institute,Department of Clinical Research
[5] University of Louisville,undefined
[6] Neoprobe Corporation,undefined
来源
Annals of Surgical Oncology | 2011年 / 18卷
关键词
Melanoma; Breast Cancer Patient; Sentinel Lymph Node; Diethylene Triamine Penta Acetic Acid; Sentinel Lymph Node Mapping;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:961 / 969
页数:8
相关论文
共 50 条
  • [1] A Phase 2 Study of 99mTc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer
    Leong, Stanley P. L.
    Kim, Julian
    Ross, Merrick
    Faries, Mark
    Scoggins, Charles R.
    Metz, Wendy L. Rich
    Cope, Frederick O.
    Orahood, Richard C.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 961 - 969
  • [2] Utility Of The 99MTC-Tilmanocept In Sentinel Lymph Node Biopsy Of Endometrial Cancer
    Laverde Machler, A.
    Suarez Fernandez, J.
    Vigil Diaz, C.
    Lisei Coscia, D.
    Marana Gonzalez, J.
    Rodriguez Diaz, L.
    Dominguez Grande, M.
    Martin Fernandez, N.
    Gonzalez Garcia, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S167 - S167
  • [3] Mapping lymph nodes in cancer management - role of 99mTc-tilmanocept injection
    Tausch, Christoph
    Baege, Astrid
    Rageth, Christoph
    ONCOTARGETS AND THERAPY, 2014, 7 : 1151 - 1158
  • [4] Sentinel lymph node detection in oral cancer: a head to head comparison between 99mTc-Tilmanocept and 99mTc-Nanocoll
    den Toom, I. J.
    Mahieu, R.
    van Rooij, R.
    van Es, R. J. J.
    de Keizer, B.
    de Bree, R.
    ORAL ONCOLOGY, 2021, 118
  • [5] In-use stability of 99mTc-tilmanocept (Lymphoseek®), a sentinel lymph node detection agent
    Green, R. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S432 - S432
  • [6] Early Experience With 99mTc-Tilmanocept For Sentinel Node Detection In Head And Neck Cancer
    Tartaglione, G.
    Caggiati, A.
    Maggiore, M.
    Ieria, F. P.
    Vigili, M. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S482 - S483
  • [7] Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer
    Vidal-Sicart, Sergi
    Eugenia Rioja, Maria
    Prieto, Andrea
    Goni, Elena
    Gomez, Isabel
    Dolores Albala, Maria
    Lumbreras, Luis
    Fernanda Leon, Luisa
    Ramon Gomez, Jose
    Campos, Francisco
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 620 - 627
  • [8] Comparison of 99mTc-Tilmanocept and 99mTc-Sulfur Colloid for Intraoperative Lymphatic Mapping and Sentinel Lymph Node Biopsy in Breast Cancer Patients
    Kardan, Arash
    Weighall, Roxane
    Sayre, James
    Weaver, Melanie
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [9] A prospective open label phase 3 trial of receptor-targeted 99mTc-tilmanocept for sentinel node evaluation in breast cancer and melanoma
    Sondak, Vernon
    Wallace, Anne
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [10] A phase III study of receptor-targeted 99mTc-tilmanocept versus blue dye in the evaluation of SLNs in breast cancer and melanoma
    Cope, F. O.
    Sondak, V. K.
    Wallace, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)